Adrenergic Uptake Inhibitors - Research News and Information

Wednesday, January 07, 2009

Treating thermally injured children suffering symptoms of acute stress with imipramine and fluoxetine: a randomized, double-blind study.

30 Oct 2008 INTRODUCTION: For pediatric burn patients with the symptoms of acute stress disorder (ASD) a first line medication is not widely agreed upon. A prospective, randomized, placebo controlled, double-blind design was used to test the efficacy of ... Read more...

[ADHD in adults]

18 Oct 2008 According to epidemiological surveys 1-2% of the adult population fulfil the criteria for attention-deficit hyperactivity disorder. Some need treatment which they are not currently offered. The effect of either central stimulants or atomoxetine is ... Read more...

Medication errors in the ambulatory treatment of pediatric attention deficit hyperactivity disorder.

30 Aug 2008 Of 361 reports of errors involving pediatric attention deficit hyperactivity disorder from 2003 to 2005, 82% reached the patient but were not harmful; more serious errors were ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Adrenergic Uptake Inhibitors'

These are the very latest articles for this heading:

• Treating thermally injured children suffering symptoms of acute stress with imipramine and fluoxetine: a randomized, double-blind study. 30 Oct 2008
• [ADHD in adults] 18 Oct 2008
• Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. 29 Sep 2008
• Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. 22 Sep 2008
• Medication errors in the ambulatory treatment of pediatric attention deficit hyperactivity disorder. 30 Aug 2008
• Recurrent inhibitory network among striatal cholinergic interneurons. 25 Aug 2008
• Duloxetine-associated tachycardia. 24 Aug 2008
• Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS). 6 Aug 2008
• A case of apical ballooning cardiomyopathy associated with duloxetine. 3 Aug 2008
• Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. 30 Jul 2008
• Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. 30 Jul 2008
• Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder? 30 Jul 2008
• Medications for adolescents with attention-deficit/hyperactivity disorder. 30 Jul 2008
• Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons. 22 Jul 2008
• Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret. 13 Jul 2008
• Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials. 29 Jun 2008
• A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. 29 Jun 2008
• Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 29 Jun 2008
• The impact of analytic method on interpretation of outcomes in longitudinal clinical trials. 26 Jun 2008
• Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells. 2 Jun 2008

See a longer list of these articles.

Technical information about 'Adrenergic Uptake Inhibitors'

Definition: Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.

Registry Number: 0

Descriptor UI: D018759

Alternative terms: Adrenergic Uptake Inhibitors; Reuptake Inhibitors, Adrenergic; Inhibitors, Adrenergic Uptake; Uptake Inhibitors, Adrenergic; Inhibitors, Adrenergic Reuptake; Adrenergic Reuptake Inhibitors;

Related Mesh Headings: Amphetamines; Antidepressive Agents, Tricyclic; Dopamine Uptake Inhibitors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.519.625.050.601; D27.505.519.625.600.050; D27.505.696.577.050.601; D27.505.696.577.600.050;

History Note: 95

Technical Notes: GEN or unspecified; prefer specifics; DF: ADREN UPTAKE INHIB